Brunel University Research Archive(BURA) preserves and enables easy and open access to all
types of digital content. It showcases Brunel's research outputs.
Research contained within BURA is open access, although some publications may be subject
to publisher imposed embargoes. All awarded PhD theses are also archived on BURA.
Search
Add filters:
Use filters to refine the search results.
Item hits:
| Issue Date | Title | Author(s) |
|---|---|---|
| 2011 | Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas | Cantilena, S; Pastorino, F; Pezzolo, A; Chayka, O; Pistoia, V; Ponzoni, M; Sala, A |
| 2012 | A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma | Sottile, F; Gnemmi, I; Cantilena, S; D'Acunto, WC; Sala, A |
| 2013 | Polyphenon E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells | Santilli, G; Piotrowska, I; Cantilena, S; Chayka, O; D'Alicarnasso, M; Morgenstern, DA; Himoudi, N; Pearson, K; Anderson, J; Thrasher, AJ; Sala, A |
| 2009 | Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas | Chakya, O; Corvetta, D; Dews, M; Caccamo, AE; Piotrowska, I; Santilli, G; Gibson, S; Sebire, NJ; Himoudi, N; Hogarty, MD; Anderson, J; Bettuzzi, S; Thomas-Tikhonenko, A; Sala, A |
| 2016 | Cutaneous cylindroma: it's all about MYB | Corda, G; Sala, A |
| 2016 | A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastoma | Dvorkina, M; Nieddu, V; Chakelam, S; Pezzolo, A; Cantilena, S; Leite, AP; Chayka, O; Regad, T; Pistorio, A; Sementa, AR; Virasami, A; Barton, J; Montano, X; Lechertier, T; Brindle, N; Morgenstern, D; LE Bras, M; Burns, A; Saunders, N; Hodivala-Dilke, K; Bagella, L; de The, H; Anderson, J; Sebire, N; Pistoia, V; Sala, A; Salomoni, P |
| 2013 | Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: Functional and therapeutic implications | Corvetta, D; Chayka, O; Gherardi, S; D'Acunto, CW; Cantilena, S; Valli, E; Piotrowska, I; Perini, G; Sala, A |
| 16-Feb-2020 | ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma | Andersson, MK; Mangiapane, G; Nevado, PT; Tsakaneli, A; Carlsson, T; Corda, G; Nieddu, V; Abrahamian, C; Chayka, O; Rai, L; Wick, M; Kedaigle, A; Stenman, G; Sala, A |
| 9-Nov-2016 | Functional and prognostic significance of the genomic amplification of frizzled receptor 6 ( FZD6 ) in breast cancer | Corda, G; Sala, G; Lattanzio, R; Iezzi, M; Sallese, M; Fragassi, G; Lamolinara, A; Mirza, H; Barcaroli, D; Ermler, S; Silva, E; Yasaei, H; Newbold, RF; Vagnarelli, P; Mottolese, M; Natali, PG; Perracchio, L; Quist, J; Grigoriadis, A; Marra, P; Tutt, AN; Piantelli, M; Iacobelli, S; De Laurenzi, V; Sala, A |
| 15-Oct-2020 | Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma | Capone, E; Lamolinara, A; Pastorino, F; Gentile, R; Ponziani, S; Di Vittorio, G; D’Agostino, D; Bibbò, S; Rossi, C; Piccolo, E; Iacobelli, V; Lattanzio, R; Panella, V; Sallese, M; De Laurenzi, V; Giansanti, F; Sala, A; Iezzi, M; Ponzoni, M; Ippoliti, R; Iacobelli, S; Sala, G |
Discover
Subject
Date issued